CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.
Astori A, Fredly H, Aloysius TA, Bullinger L, Mansat-De Mas V, de la Grange P, Delhommeau F, Hagen KM, Récher C, Dusanter-Fourt I, Knappskog S, Lillehaug JR, Pendino F, Bruserud Ø.
Astori A, et al. Among authors: hagen km.
Oncotarget. 2013 Sep;4(9):1438-48. doi: 10.18632/oncotarget.1195.
Oncotarget. 2013.
PMID: 23988457
Free PMC article.